Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension
Author(s) -
François Lamontagne,
Alvin RichardsBelle,
Karen Thomas,
David A Harrison,
Zia Sadique,
Richard Grieve,
Julie Camsooksai,
Robert Darnell,
Anthony Gordon,
Doreen Henry,
N Hudson,
Alexina J. Mason,
Michelle Saull,
Chris Whitman,
Duncan Young,
Kathy Rowan,
Paul Mouncey
Publication year - 2020
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2020.0930
Subject(s) - medicine , randomized controlled trial , anesthesia , blood pressure , intensive care unit , norepinephrine , permissive , mean arterial pressure , heart rate , virology , dopamine
Vasopressors are commonly administered to intensive care unit (ICU) patients to raise blood pressure. Balancing risks and benefits of vasopressors is a challenge, particularly in older patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom